Targeting the neurovascular unit: Development of a new model and consideration for novel strategy for Alzheimer's disease

Brain Research Bulletin

Volumn 86, Issue 1-2, 2011, Pages 13-21

  Liu, Rui ^a   Zhang, Tian tai ^a   Wu, Cai xia ^a,b   Lan, Xi ^a   Du, Guan hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid peptide; Blood brain barrier; Cerebral microvascular endothelial cells; Neurovascular unit

Indexed keywords

ACETYLCHOLINESTERASE; ALKALINE PHOSPHATASE; F ACTIN; GAMMA GLUTAMYLTRANSFERASE; INTERCELLULAR ADHESION MOLECULE 1; OCCLUDIN; PROTEIN ZO1; RIVASTIGMINE; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN MITOCHONDRION; BRAIN NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; MALE; MICROVASCULAR ENDOTHELIAL CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICROCIRCULATION; MODELS, NEUROLOGICAL; NEURONS; RATS; RATS, WISTAR; TIGHT JUNCTIONS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80051588364     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.05.015     Document Type: Article

References (66)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
3. Butt A.M., Jones H.C., Abbott N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 1990, 429:47-62.
4. Cecchelli R., Dehouck B., Descamps L., Fenart L., Buée-Scherrer V.V., Duhem C., Lundquist S., Rentfel M., Torpier G. M. P. Dehouck In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36:165-178.
5. Coyle J.T., Price D.L., Delong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219:1184-1190.
6. Crouch P.J., White A.R., Bush A.I. The modulation of metal bioavailability as a therapeutic strategy for the treatment of Alzheimer's disease. FEBS J. 2007, 274:3775-3783.
7. Culot M., Lundquist S., Vanuxeem D., Nion S., Landry C., Delplace Y., Dehouck M.P., Berezowski V., Fenart L., Cecchelli R. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol. In Vitro 2008, 22:799-811.
8. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004, 3:184-190.
9. de la Torre J.C., Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurol. Res. 1993, 15:146-153.
10. Dehouck M.P., Meresse S., Delorme P., Fruchart J.C., Cecchelli R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J. Neurochem. 1990, 54:1798-1801.
11. el Hafny B., Bourre J.M., Roux F. Synergistic stimulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J. Cell Physiol. 1996, 167:451-460.
12. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001, 64:575-611.
13. Fisher M. Pericyte signaling in the neurovascular unit. Stroke 2009, 40:S13-15.
14. Frey A., Meckelein B., Weiler-Guttler H., Mockel B., Flach R., Gassen H.G. Pericytes of the brain microvasculature express gamma-glutamyl transpeptidase. Eur. J. Biochem. 1991, 202:421-429.
15. Gaillard P.J, Voorwinden L.H., Nielsen J.L., Ivanov A., Atsumi R., Engman H., Ringbom C., de Boer A.G., Breimer D.D. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 2001, 12:215-222.
16. Grant G.A., Abbott N.J., Janigro D. Understanding the physiology of the blood-brain barrier: in vitro models. News Physiol. Sci. 1998, 13:287-293.
17. Gumbleton M., Audus K.L. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J. Pharm. Sci. 2001, 90:1681-1698.
18. Han B.H., Zhou M.L., Abousaleh F., Brendza R.P., Dietrich H.H., Koenigsknecht-Talboo J., Cirrito J.R., Milner E., Holtzman D.M., Zipfel G.J. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J. Neurosci. 2008, 28:13542-13550.
19. Harhaj N.S., Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 2004, 36:1206-1237.
20. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 1997, 110:1603-1613.
21. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
22. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging 2000, 21:321-330.
23. Kalaria R.N. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol. Aging 2009, 30:1512-1514.
24. Kasa P., Pakaski M., Joó F., Lajtha A. Endothelial cells from human fetal brain microvessels may be cholinoceptive, but do not synthesize acetylcholine. J. Neurochem. 1991, 56:2143-2146.
25. Kawashima K., Ishikawa H., Mochizuki M. Radioimmunoassay for acetylcholine in the rat brain. J. Pharmacol. Methods 1980, 3:115-123.
26. Kawashima K., Hayakawa T., Kashima Y., Suzuki T., Fujimoto K., Oohata H. Determination of acetylcholine release in the striatum of anesthetized rats using in vivo microdialysis and a radioimmunoassay. J. Neurochem. 1991, 57:882-887.
27. Kawashima K., Fujii T., Watanabe Y., Misawa H. Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes. Life Sci. 1998, 62:1701-1705.
28. Kneisel U., Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol. Neurobiol. 2000, 20:57-76.
29. Kugelman A., Choy H.A., Liu R., Shi M.M., Gozal E., Forman H.J. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am. J. Respir. Cell Mol. Biol. 1994, 11:586-592.
30. Lin C.J., Huang H.C., Jiang Z.F. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains. Brain Res. Bull. 2010, 82:235-242.
31. Liu R., Gao M., Yang Z.H., Du G.H. Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro. Brain Res. 2008, 1216:104-115.
32. Liu R., Gao M., Qiang G.F., Zhang T.T., Lan X., Ying J., Du G.H. The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience 2009, 162:1232-1243.
33. 25-35-induced toxicity on rat cerebral microvascular endothelial cells. Chin. J. Nat. Med. 2010, 8:223-227.
34. Liu R., Zhang T., Yang H., Lan X., Ying J., Du G. The Flavonoid Apigenin Protects Brain Neurovascular Coupling against Amyloid-beta25-35-Induced Toxicity in Mice. J. Alzheimers Dis. 2011, 24:85-100.
35. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
36. Lok J., Gupta P., Guo S., Kim W.J., Whalen M.J., van Leyen K., Lo E.H. Cell-cell signaling in the neurovascular unit. Neurochem. Res. 2007, 32:2032-2045.
37. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
38. Mazzone M., Carmeliet P. Drug discovery: a lifeline for suffocating tissues. Nature 2008, 453:1194-1195.
39. Mertsch K., Maas J. Blood-brain barrier penetration and drug development from an industrial point of view. Curr. Med. Chem. 2002, 2:187-201.
40. Meyer J., Mischeck U., Veyhl M., Henzel K., Galla H.J. Blood-brain barrier characteristic enzymatic properties in cultured brain capillary endothelial cells. Brain Res. 1990, 514:305-309.
41. Naik R.S., Hartmann J., Kiewert C., Duysen E.G., Lockridge O., Klein J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J. Pharm. Pharm. Sci. 2009, 12:79-85.
42. Nusrat A., Turner J.R., Madara J.L. Molecular physiology and pathophysiology of tight junctions IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G851-G857.
43. Parhami F., Morrow A.D., Balucan J., Leitinger N., Watson A.D., Tintut Y., Berliner J.A., Demer L.L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 1997, 17:680-687.
44. Perrière N., Demeuse P., Garcia E., Regina A., Debray M., Andreux J.P., Couvreur P., Scherrmann J.M., Temsamani J., Couraud P.O., Deli M.A., Roux F. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem. 2005, 93:279-289.
45. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006, 1:223-236.
46. Qiu C., von Strauss E., Fastbom J., Winblad B., Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch. Neurol. 2003, 60:223-228.
47. Roman G.C., Kalaria R.N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 2006, 27:1769-1785.
48. Rosengarten B., Paulsen S., Burr O., Kaps M. Neurovascular coupling in Alzheimer patients: effect of acetylcholineesterase inhibitors. Neurobiol Aging 2009, 30:1918-1923.
49. Roux F., Durieu-Trautmann O., Chaverot N., Claire M., Mailly P., Bourre J.M., Strosberg A.D., Couraud P.O. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell Physiol. 1994, 159:101-113.
50. Sato A., Sato Y., Uchida S. Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Auton. Neurosci. 2002, 96:13-19.
51. Savettieri G., Di Liegro I., Catania C., Licata L., Pitarresi G.L., D'Agostino S., Schiera G., De Caro V., Giandalia G., Giannola L.I., Cestelli A. Neurons and ECM regulate occludin localization in brain endothelial cells. NeuroReport 2000, 11:1081-1084.
52. Shin H.K., Jones P.B., Garcia-Alloza M., Borrelli L., Greenberg S.M., Bacskai B.J., Frosch M.P., Hyman B.T., Moskowitz M.A., Ayata C. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007, 130:2310-2319.
53. Singh J., Chander J., Singh S., Singh G., Atal C.K. Gamma-glutamyl transpeptidase: a novel biochemical marker in inflammation. Biochem. Pharmacol. 1986, 35:3753-3760.
54. Tu Y., Kroener S., Abernathy K., Lapish C., Seamans J., Chandler L.J., Woodward J.J. Ethanol inhibits persistent activity in prefrontal cortical neurons. J. Neurosci. 2007, 27:4765-4775.
55. van Oijen M., de Jong F.J., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Atherosclerosis and risk for dementia. Ann. Neurol. 2007, 61:403-410.
56. Whitehouse P.J. Paying attention to acetylcholine: the key to wisdom and quality of life?. Prog. Brain Res. 2004, 145:311-317.
57. Wilcock D.M., Vitek M.P., Colton C.A. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 2009, 159:1055-1069.
58. Wolf S., Gassen H.G. Gamma-glutamyl transpeptidase, a blood-brain barrier associated membrane protein, Splitting peptides to transport amino acids. Adv. Exp. Med. Biol. 1997, 421:37-45.
59. Xu W.L., Qiu C.X., Wahlin A., Winblad B., Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004, 63:1181-1186.
60. Youakim A., Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 1999, 276:G1279-G1288.
61. Yu C., Kastin A.J., Ding Y., Pan W. Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp. Neurol. 2007, 203:116-122.
62. Zehendner C.M., Luhmann H.J., Kuhlmann C.R. Studying the neurovascular unit: an improved blood-brain barrier model. J. Cereb. Blood Flow Metab. 2009, 29:1879-1884.
63. Zhang X.Z., Li X.J., Zhang H.Y. Valproic acid as a promising agent to combat Alzheimer's disease. Brain Res. Bull. 2010, 81:3-6.
64. Zhou Y., Shi G., Zheng J., Huang Z., Gao F., Zhang Y., Guo F., Jia Q., Zheng Y. The protective effects of Egr-1 antisense oligodeoxyribonucleotide on cardiac microvascular endothelial injury induced by hypoxia-reoxygenation. Biochem. Cell Biol. 2010, 88:687-695.
65. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28:202-208.
66. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.